News tagged with competitiveness
(AP) -- George Eberhardt turned 107 last month, and scientists would love to know how he and other older folks like him made it that far. So he's going to hand over some of his DNA. He's one of 100 centenarians ...
Genetics Oct 26, 2011 | 4.4 / 5 (11) | 5
The fourth-quarter comeback to win the game. The tumor that appeared on a second scan. The guy in accounting who was secretly embezzling company funds. The situation may be different each time, but we hear ourselves say it ...
Psychology & Psychiatry Sep 06, 2012 | 4.8 / 5 (5) | 2 |
The shape of a man's face can help predict his sporting acumen, according to a study on Wednesday that found Japanese baseball players whose faces were relatively broad rather than long were most likely to ...
Other Apr 09, 2013 | 2.5 / 5 (8) | 1
(AP)—The Obama administration appealed a federal judge's order to lift all age limits on who can buy morning-after birth control pills without a prescription. In appealing the ruling on Wednesday, the administration ...
Medications May 02, 2013 | 4 / 5 (1) | 0
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
Other May 02, 2013 | not rated yet | 0
Britain's competition watchdog accused GlaxoSmithKline on Friday of paying off competitors to delay launches of their own versions of GSK's best-selling antidepressant, Seroxat.
Medications Apr 19, 2013 | not rated yet | 1
Pfizer Inc.'s first-quarter net income rose 53 percent despite falling sales, mainly because the world's second-largest drugmaker took big charges a year ago. Pfizer's results fell short of Wall Street's ...
Other Apr 30, 2013 | not rated yet | 0
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Medications Apr 16, 2013 | not rated yet | 1
(AP) -- The Food and Drug Administration is preparing to review the first lower-cost versions of biotech drugs, expensive medications which have never before faced generic competition.
Medications Feb 09, 2012 | not rated yet | 1
(Medical Xpress)—Certificate of Need, a form of state government regulation designed to keep mortality rates and health care costs down, appears to do neither for heart bypass surgery, according to a health economics researcher ...
Cardiology Oct 03, 2012 | not rated yet | 0
(Medical Xpress) -- Whether you are an elite athlete trying to gain a competitive edge, or a regular bike commuter, consuming caffeine one hour prior to exercise has the potential to improve your performance.
Health Mar 21, 2012 | not rated yet | 0
Peers exert a greater influence on teenage girls' dissatisfaction with their bodies than do thin ideals in television or social media use, according to new research by Dr. Christopher J. Ferguson and colleagues from Texas ...
Health Jan 30, 2013 | 5 / 5 (1) | 0
They say the real crisis stems from current incentives that reward companies for developing large numbers of new drugs with few clinical advantages over existing ones.
Medications Aug 07, 2012 | 5 / 5 (1) | 0
Moving in harmony can make people feel more connected to one another and, as a result, lead to positive collective action. Think of those feel-good vibes created in a yoga class as students move in unison through their downward-facing ...
Psychology & Psychiatry Jan 11, 2012 | 5 / 5 (2) | 3
The U.S. Justice Department is investigating drug maker Sanofi's disclosures to the Food and Drug Administration about different responses to its blockbuster blood thinner Plavix.
Medications Mar 11, 2013 | not rated yet | 0
Competitiveness is a comparative concept of the ability and performance of a firm, sub-sector or country to sell and supply goods and/or services in a given market. Although widely used in economics and business management, the usefulness of the concept, particularly in the context of national competitiveness, is vigorously disputed by economists, such as Paul Krugman.
The term may also be applied to markets, where it is used to refer to the extent to which the market structure may be regarded as perfectly competitive. This usage has nothing to do with the extent to which individual firms are "competitive'.
For more information about Competitiveness, read the full article at
This text uses material from Wikipedia and is available under the GNU Free Documentation License.